Testament to the success of Medica Linea Pharm’s business development strategy, defined by a limited number of suppliers and an ambition to increase quality vis-a-vis quality, is the 40% annual turnover growth witnessed in the period between 2016 and 2019. Approximately 25% of revenue derives

As part of the growth strategy and vision, a new department for Medical Devices is incorporated within the company. Medica Linea Pharm now offers services to manufacturers of every type of medicinal product.

The success of the new strategy, and large growth investments become evident as revenue increases up to €7.5mn at the end of the fiscal year.

The company undergoes a major restructuring, turning the focus and strategy into one of delivering services necessary for growth.

Medica Linea Pharm d.o.o. is founded with the vision of providing the highest quality of services for key pharmaceutical partners.